Splice switching oligomers for TNF superfamily receptors and their use in treatment of disease

Details for Australian Patent Application No. 2007352163 (hide)

Owner Santaris Pharma A/S Ercole Biotech, Inc.

Inventors Sazani, Peter L.; Orum, Henrik

Agent Pizzeys

Pub. Number AU-A-2007352163

PCT Pub. Number WO2008/131807

Priority 11/799,117 01.05.07 US; PCT/ US2007/010556 01.05.07 US

Filing date 19 October 2007

Wipo publication date 6 November 2008

International Classifications

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/131807 Priority application(s): WO2008/131807

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007352211-Sleeve for a transfixation device for an external skeletal fixator

2007352140-A process for the production of organic formulation of bio-pesticide pseudomonas fluorescens